Disease: Chronic lymphocytic leukemia
- A <em>POT1</em> Founder Variant Associated with Early Onset Recurrent Melanoma and Various Solid Malignancies
- A decade of chronic lymphocytic leukaemia therapy in Germany: Real-world treatment patterns and outcomes (2010-2022)
- A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
- A Rare Case of an Elderly Male with Progression to Chronic Myeloid Leukaemia Secondary to Chronic Lymphocytic Leukaemia
- Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: Pooled analysis of 5 clinical trials
- An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL
- Analysis of Primary Chronic Lymphocytic Leukemia Cells' Signaling Pathways
- Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon
- Assessment and prognostic significance of a serum cytokine panel in diffuse large B-cell lymphoma
- Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
- Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article
- Associations between eosinophils and cancer risk in the UK Biobank
- B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy
- B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice
- Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial
- Biological characteristics and clinical significance of stereotyped B-cell receptor in chronic lymphocytic leukemia
- Blocking Orai1 constitutive activity inhibits B-cell cancer migration and synergistically acts with drugs to reduce B-CLL cell survival
- CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression
- Chronic lymphocytic leukaemia in the elderly
- Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course
- Chronic Lymphocytic Leukemia Producing Infiltrative Orbitopathy Masquerading as Thyroid Eye Disease
- Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
- Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Reply
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024
- Clinical Risks for Chronic Lymphocytic Leukemia
- Clinical utility of CLL-IPI scoring system in Pakistani Chronic Lymphocytic Patients: A single center experience
- CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
- Composite Histiocytic Sarcoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma of the Ocular Adnexa
- COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study
- COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study
- Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review
- Cutaneous involvement in chronic lymphocytic leukaemia
- Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2
- Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms
- Eosinophilic Pustular Folliculitis in the Setting of Untreated Chronic Lymphocytic Leukemia
- Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry
- Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia
- False positive multifocal PSMA PET/CT in a patient with prostate cancer and B cell chronic lymphocytic leukemia
- Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry
- Highlights in chronic lymphocytic leukemia from the 65th ASH Annual Meeting and Exposition
- Highlights in chronic lymphocytic leukemia from the 65th ASH Annual Meeting and Exposition: commentary
- HSR24-164: Predicting Treatment-Related Fatigue in the Context of Lymphoma and Chronic Lymphocytic Leukemia
- Ibrutinib in CLL: benefit for all?
- Ibrutinib-associated cutaneous mucormycosis due to an <em>Apophysomyces</em> species: report of a case and review of the literature
- Ibrutinib-induced pneumonitis in chronic lymphocytic leukemia patient
- IkappaBepsilon deficiency accelerates disease development in chronic lymphocytic leukemia
- Immune Thrombocytopenic Purpura Associated With Systemic Lupus Erythematosus, Helicobacter pylori, and Hepatitis B
- Improved Survival of Patients With Chronic Lymphocytic Leukemia Between 1998-2022, Including the Era of Target Therapies With BCL2 and BTK Inhibitors
- In vitro Immunostimulant Activity of the Polyphenolic Extract from the Arctic Brown Algae Fucus vesiculosus
- Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review
- Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment
- Linc01588 deletion inhibits the malignant biological characteristics of hydroquinone-induced leukemic cells via miR-9-5p/SIRT1
- Long-read single-cell RNA sequencing enables the study of cancer subclone-specific genotype and phenotype in chronic lymphocytic leukemia
- Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies
- MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases
- Monoclonal Gammopathy of Renal Significance (MGRS) - Case Series from a Tertiary Center in Kerala
- Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia
- Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia
- New means and challenges in the targeting of BTK
- Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells
- Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects
- Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma
- Post polycythemia vera myelofibrosis with myelodysplastic-like progression in a patient with chronic lymphocytic leukemia
- Potential New Therapies "ROS-Based" in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis
- Predicting Stage Progression in Binet Stage a Chronic Lymphocytic Leukemia
- Presumed pseudo-Pelger-Huet anomaly and basophilia secondary to chronic lymphocytic leukemia in a dog
- Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)
- Pseudo-Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma After Temporary Acalabrutinib Interruption
- Pseudohyperkaliémie en contexte de leucémie lymphoïde chronique
- QIM24-184: Monitoring Concordance of Chronic Lymphocytic Leukemia (CLL) at Watson Clinic LLP: Diagnosis & Treatment
- Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL
- Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting
- Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study
- Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
- Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
- Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies
- Research Progress of Targeted Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma --Review
- Resolution of metastatic neck nodes associated with a periauricular cutaneous squamous cell carcinoma after intranodal injection of talimogene laherparepvec
- Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque
- Sepsis Unveils T-cell Large Granular Lymphocytic Leukemia in the Setting of End-Stage Renal Disease: A Rare Hematologic Malignancy
- Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma
- Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison
- Six-year update of the ELEVATE-TN study on acalabrutinib
- SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders
- Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial
- Successful treatment of <em>Purpureocillium lilacinum</em> pulmonary infection with isavuconazole: A case report
- T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia
- The malignant transformation potential of the oncogene STYK1/NOK at early lymphocyte development in transgenic mice
- The prognostic significance of genomic complexity in patients with CLL
- The role of polymorphic cytochrome P450 gene (CYP2B6) in B-chronic lymphocytic leukemia (B-CLL) incidence and outcome among Egyptian patients
- Translation of Data from Animal Models of Cancer to Immunotherapy of Breast Cancer and Chronic Lymphocytic Leukemia
- Treatment adherence and adverse event management in chronic lymphocytic leukemia: challenges and strategies for the future
- Treatment of relapsed/refractory chronic lymphocytic leukemia with Zanubrutinib after progressing on other BTK inhibitors
- Two recurrent types of <em>IGH</em>::5' <em>BCL2</em> breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the <em>VDJ</em> and class switch recombination processes, respec
- Vanillic acid protects mortality and toxicity induced by N-ethyl-N-nitrosourea in mice; in vivo model of chronic lymphocytic leukemia
- Venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia
- Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management
- Viable mutations of mouse midnolin suppress B cell malignancies
- White Blood Cell Count, Neutrophil-to-Lymphocyte Ratio, and Incident Cancer in the UK Biobank
- Zanubrutinib-induced petechial ecchymotic reaction in a previously irradiated area in a patient with chronic lymphocytic leukemia